Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.

International journal of molecular sciences - 25 Jan 2023

Liu Chia-Hsin, Di Yuanpu Peter

Abstract excerpt

Tumor recurrence poses a significant challenge to the clinical management of stage I lung adenocarcinoma after curative surgical resection. Matrix metalloproteinases (MMPs) increase expression and correlate with recurrence and metastasis in surgically resected non-small cell lung cancer. However, the impact of MMPs on survival outcome varies, and their roles in patients with stage I lung adenocarcinoma remain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Matrix Metalloproteinases

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Source

Open in PubMed Open full text

Identifiers

PMID: 36768704
DOI: 10.3390/ijms24032382
PMCID: PMC9917043

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.PMID 36768704Read ↗

An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.Semantic proximity Read ↗

A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung CancerSemantic proximity Read ↗

MMP expression profiling in recurred stage IB lung cancerSemantic proximity Read ↗

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancerSemantic proximity Read ↗

Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent DiseaseSemantic proximity Read ↗

MMP11 is associated with the immune response and immune microenvironment in EGFR-mutant lung adenocarcinomaSemantic proximity Read ↗

Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses.Semantic proximity Read ↗

A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

EGFR Mutation Impacts Recurrence in High-Risk Early-Stage Lung Adenocarcinoma in the IASLC Grading SystemSemantic proximity Read ↗

Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.Semantic proximity Read ↗

DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical managementSemantic proximity Read ↗

Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.